184: Chapter 184 Medical Miracle: Nanorobots Eliminate Cancer Cells

"Bright Dawn" base, underground level 18, Life Science and Medical Technology Research Center.

The air here was clean to the point of being sterile, carrying a faint, peculiar scent reminiscent of ozone mixed with organic solvents. On both sides of the silvery-white corridor were transparent isolation laboratories, where researchers in full protective gear were busy in front of various precision instruments. Unlike the vibrant energy of the agricultural zone, the atmosphere here was more solemn and cautious, with every movement seemingly calculated with precision.

Lin Mo stood on the central observation platform, facing a massive circular screen displaying dozens of split-screen experimental scenes and data streams. He was not wearing protective gear, operating only through the sterile isolation observation window and remote system. Beside him stood an elderly man with graying hair and a serious expression—the Chairman of the Global Medical Ethics Committee, Academician Shen Huaishan.

"Consultant Lin, the summary of the seventy-third batch of in vivo test data for the 'Scavenger-Type A' medical nanobots is complete." The chief researcher's voice came through the communicator, suppressing a hint of excitement amidst the calm.

In the center of the screen, a shocking microscopic image was magnified.

In a simulated human tissue environment, a tiny tumor (taken from an experimental mouse) was growing. Suddenly, silvery-gray "particles" with complex geometric surfaces, dozens of times smaller than red blood cells, began to appear near the blood vessels. They seemed to possess some form of intelligence, precisely attaching themselves to the vessel walls before "melting" like liquid metal to penetrate the vessel walls and enter the interstitial space.

The next scene made even the experienced Academician Shen Huaishan hold his breath.

These nanobots did not rush directly at the tumor cells. They first "assembled" at the junction of healthy and tumor tissues, releasing certain signal molecules. Soon, specific protein markers on the surface of the tumor cells were highlighted—these were the "ID cards" that distinguished cancer cells from normal cells.

After confirming the target, the swarm of nanobots began a "surgery" that was shockingly efficient.

Some robots released precise enzymes, like tiny keys, to open specific channels on the tumor cell membranes. Others "drilled" into the cells along these channels, directly targeting the nucleus, releasing the "gene scissors" they carried to precisely cut out the key oncogene segments causing the cells to proliferate infinitely, or inducing them to initiate programmed cell death.

Other robots were specifically responsible for "cleaning the battlefield" and "repairing damage." They cleared the debris after cell apoptosis, released factors to promote the regeneration and repair of surrounding healthy cells, and could even temporarily replace the function of damaged micro-vessels to maintain local blood circulation.

Read the latest and fastest updated chapters on NovelFull.in

The entire process was fast, precise, and quiet. Data in the corner of the screen showed that the clearance operation for this tiny tumor was completed in four minutes and seventeen seconds. The tumor tissue was completely cleared, the surrounding healthy tissue was almost undamaged, and the only slight inflammatory reaction was quickly calmed by the regulatory factors released by the nanobots.

"Clearance rate 99.97%, non-target tissue damage rate less than 0.01%, postoperative local microenvironment repair index excellent..." Academician Shen Huaishan slowly read out the conclusion data, his aged fingers trembling slightly. "This... this has exceeded the limits of precision and safety of all current radiotherapy, chemotherapy, targeted drugs, and even immunotherapy. It is simply... a decapitation strike by special forces at the microscopic level."

"Based on the reverse engineering of the 'the piercer' liquid metal material and its adaptive algorithms." The person in charge of social model analysis for "Fuxi" (who was also concurrently in charge of medical technology assessment at this moment) explained, "We drew on the principles of its microscopic structural deformation, energy field perception, and target recognition to design this integrated 'perception-recognition-execution-repair' nanobot system. They do not possess strong artificial intelligence themselves but possess swarm intelligence behavioral patterns based on preset programs and simple environmental feedback."

Lin Mo nodded and looked at Academician Shen Huaishan: "Academician Shen, what is the opinion of the Ethics Committee?"

Academician Shen Huaishan adjusted his glasses, his expression extremely serious: "The technology itself is a miracle. But the risks are equally huge. First, long-term safety. Will these nanomaterials remain in the body, causing unknown long-term toxicity or immune reactions? Second, controllability. How do we ensure they can be safely metabolized or recovered after completing the task? What if the program goes wrong and attacks healthy cells? Third, and most importantly—the scope of application and fairness. Which diseases are applicable? Who is qualified to use them first? Will it exacerbate social inequality?"

His questions were sharp and direct, representing the conscience that a responsible scientific community must face.

"Your questions are exactly the focus of our all-out efforts over the past three months." Lin Mo pulled up several other reports. "Regarding long-term safety, we have designed biodegradable shells and cores. After completing the task or reaching the preset lifespan, the robots will automatically disintegrate into amino acids and metal ions that are harmless to the human body and excreted through metabolism. All materials have undergone over a thousand cytotoxicity and immunogenicity tests."

"Regarding controllability, each batch of nanobots has built-in dual safety instructions and self-destruct switches. In addition to the preset disease target recognition program, they will monitor host environmental parameters in real-time. Once an abnormality occurs (such as large-scale attacks on healthy tissue, or a sharp deterioration in the host's vital signs), or if they receive an external termination signal at a specific frequency, they will immediately stop operations and initiate self-destruct procedures."

He paused and pointed to the last thick document drafted by the GDA Legal and Ethics Department: "Regarding the scope of application and fairness, the core principle of the 'Civilization Cornerstone Plan' medical branch is 'universal benefit' and 'safeguarding'. We propose to strictly limit the application of the first batch of 'Scavenger-Type A' robots to patients with late-stage malignant tumors where current traditional therapies have extremely poor results or unbearable side effects, certain specific hereditary terminal illnesses, and severe tissue defect repair caused by war wounds. All treatments will be included in the GDA unified medical security system, allocated according to the urgency of the condition and medical resources, and completely free of charge."

"At the same time," Lin Mo added, "we will recruit volunteers globally to conduct strict, phased clinical trials, with full transparency, open data, and acceptance of supervision by the Ethics Committee and the global public. Technology must serve life, not create new privileges or fear."

Academician Shen Huaishan stared for a long time at the microscopic image on the screen that had already been cleared, and then looked at the detailed risk assessment and ethical framework. Finally, he let out a long sigh, a glimmer of tears flashing in his eyes, and nodded slowly: "If... if all this can be strictly implemented, then, on behalf of the Ethics Committee, I agree in principle to start the first phase of clinical trials. This may... be the most critical step in the history of human struggle against disease."

The green light of ethics turned on under cautious and strict conditions.

The news could not, and did not need to be, completely sealed. When the first late-stage pancreatic cancer patient who voluntarily participated in the clinical trial received the nanobot injection treatment, and two weeks later, imaging examinations showed that multiple metastatic lesions in the body had significantly shrunk or even disappeared, while the patient had not experienced the pain of traditional chemotherapy except for mild flu-like immune reactions... the news was like a giant rock thrown into a calm lake, stirring up not just ripples, but a wave of hope sweeping the globe!

Success stories of more volunteers were continuously disclosed (under the premise of protecting privacy). Lung cancer, liver cancer, leukemia... after one disease name that once meant a desperate verdict, words like "significant remission," "lesion clearance," "long-term survival with tumor," and even "clinical cure" began to appear frequently.

Meanwhile, other medical applications derived from the same platform technology also began to emerge: "Vascular Scavenger" nanobots could precisely clear blood clots to prevent heart attacks and strokes; "Trauma Repairers" could accelerate the healing of severe trauma and burns, reducing scarring; "Neural Weavers" showed amazing potential in animal experiments for spinal cord injury and peripheral nerve repair...

Of course, doubts and worries never stopped. Intense debates about technological monopoly, potential abuse, and the philosophy of "playing God" took place on online platforms under GDA supervision. But one consensus was rapidly forming: when the threat of alien "Purifiers" hung over like the Sword of Damocles, allowing as many people as possible to get rid of suffering and possess a healthy body was in itself the most powerful civilizational defense—a civilization composed of healthy, vibrant individuals would have the most resilient will and the most enduring combat effectiveness.

In hospitals, scenes of patients declared "clinically cured" hugging their families and crying were transmitted to the world after being reviewed.

At military recruitment stations, young people who had been rejected due to past medical history straightened their backs and queued up to sign up after receiving proof of cure by the new medical technology.

In factories, old workers troubled by occupational diseases or chronic illnesses regained their vitality after receiving targeted treatment and remained on critical production lines.

"Fuxi"'s social model showed that under the dual benefits of agricultural harvests and medical breakthroughs, the "social panic index" globally saw its first substantial, large-scale decline, while the curves of "civilizational identity" and "wartime production enthusiasm" rose steadily.

Lin Mo looked at the technology tree of the "Civilization Cornerstone Plan", on the branch of 【Context · Universal Healthcare and Life Security】, where the node 【Broad-spectrum Targeted Nanomedical Robots (Basic Type)】 was lit up, and began to extend downward into finer branches like 【Neural Repair】, 【Tissue Regeneration】, and 【Gene Correction】.

System points increased by another 2000.

He walked to the observation window; in the huge laboratory below, researchers were conducting final tests for the next batch of nanobots with more refined and complex functions.

The resilience of civilization was strengthening bit by bit in this visible hope and health.

Next, it was time to replace the "heart" and "skeleton" of this civilization Ark that was regaining vitality—a more fundamental and surging revolution concerning energy and materials was about to follow.

Continue Reading

Create a free account to unlock this chapter and continue reading.

Register
Prev Next